MicroRNAs (miRNAs) are endogenous short non-coding RNAs that can regulate the
expression of target genes post-transcriptionally and interact with mRNA-coding genes …

Renal cell carcinoma (RCC) is a major pathological type of kidney cancer and is one of the
most common malignancies worldwide. The unremarkable symptoms of early stages …

Simple Summary The incidence of renal cell carcinoma (RCC) rises globally with the highest
rates in developed countries. This indicates not only the impact of advanced imaging, but …

Abstract MicroRNAs (miRNAs), small non-coding RNAs approximately 20–25 nt in length,
play important roles via directly binding to the corresponding 3′ UTR of target mRNAs …

Clear cell renal cell carcinoma (ccRCC) is the third most common urological cancer, and it
has the highest mortality rate. The increasing drug resistance of metastatic ccRCC has …

Introduction Tyrosine kinase (TKI) and checkpoint inhibitors (CI) prolonged overall survival
in metastatic renal cell carcinoma (mRCC). Early prediction of treatment response is highly …

Renal cell carcinoma (RCC) is the second lethal urogenital malignancy with the increasing
incidence and mortality in the world. Clear cell renal cell carcinoma (ccRCC) is one major …

The lack of symptoms at the early stages of clear cell renal cell carcinoma (ccRCC) allows
the tumour to metastasize, leading to a dramatic reduction in patient survival. Therefore, we …

Renal cell carcinoma (RCC) includes 2.2% of all diagnosed cancers and 1.8% of cancer-
related mortalities. The available biomarkers or screening methods for RCC suffer from lack …

Renal cell carcinomas (RCC) account for 2–3% of the global cancer burden and are
characterized by the highest mortality rate among all genitourinary cancers. However …